How often is a Pap (Papanicolau) test done?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pap Test Screening Frequency Guidelines

Pap tests should be performed every 3 years for women aged 21-65 years, or every 5 years with HPV co-testing for women aged 30-65 years who prefer a longer screening interval. 1

Age-Based Screening Recommendations

When to Start Screening

  • Begin cervical cancer screening at age 21 regardless of sexual history 1
  • Do NOT screen women younger than 21 years (D recommendation) 1
  • Do NOT use HPV testing alone or with cytology in women younger than 30 years (D recommendation) 1

Screening Frequency by Age Group

  • Ages 21-29 years:

    • Pap test (cytology) every 3 years 1
    • No HPV testing in this age group
  • Ages 30-65 years:

    • Option 1: Pap test (cytology) every 3 years 1
    • Option 2: Pap test plus HPV testing (co-testing) every 5 years 1

When to Stop Screening

  • Women older than 65 years who have had adequate prior screening and are not at high risk can discontinue screening 1, 2
  • "Adequate prior screening" means at least 3 consecutive negative Pap tests or 2 consecutive negative HPV and Pap co-tests within the last 10 years, with the most recent test occurring within 5 years 2

Special Populations

After Hysterectomy

  • Women who have had a hysterectomy with removal of the cervix and no history of high-grade precancerous lesions (CIN 2/3) or cervical cancer should discontinue screening 1, 2
  • Women who have undergone subtotal hysterectomy (cervix remains) should continue age-appropriate screening 2

High-Risk Women

  • Women with a history of cervical cancer, high-grade precancerous lesions, in utero DES exposure, or who are immunocompromised (e.g., HIV positive) should continue screening beyond age 65 1, 2

Screening Trends and Concerns

Recent data shows declining screening rates across all age groups, with approximately 81% of eligible women reporting having a Pap test within 3 years 3. This decline is concerning, particularly among women aged 22-30 years, where the proportion who reported never having had a Pap test increased from 6.6% to 9.0% 4.

Common Pitfalls to Avoid

  1. Annual screening is unnecessary - Despite traditional practice patterns, annual screening provides little additional benefit over the recommended 3-year interval for women aged 21-65 1

  2. Screening women under 21 - Screening women younger than 21 years is not recommended regardless of sexual activity onset, as cervical cancer is extremely rare in this age group (only 0.1% of all cervical cancers) 1

  3. Continuing screening unnecessarily after hysterectomy - Women who have had a total hysterectomy for benign disease with no history of CIN 2/3 do not need further screening 2

  4. Stopping screening too early - Never discontinue screening before age 65 in average-risk women without adequate prior screening 2

  5. Failing to verify screening history - Always document adequate prior screening before discontinuing at age 65 2

By following these evidence-based guidelines, clinicians can optimize the benefits of cervical cancer screening while minimizing potential harms from over-screening.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cervical Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cervical cancer screening among women aged 18-30 years - United States, 2000-2010.

MMWR. Morbidity and mortality weekly report, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.